A former Polymarket team member said that the POLY token will not be launched in the short term and may require a long wait.
Odaily reported that in response to community users' analysis suggesting that Polymarket might launch the POLY token in the fourth quarter of this year (or in 2028), former Polymarket team member Greg replied that "the POLY token will not be launched in the short term, and it may take a long time." In addition, Greg stated that Polymarket's advance hype of the token was purely a commercial marketing tactic, but he has now deleted his reply tweet referencing "commercial marketing."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Forge Nano completes acquisition of HzO
Crypto prices
More
